- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Board Exam Prep Quiz"
Current Top Players:
1) Dr. Steven Saunders
2) Dr. Nalini Shah
3) Dr. Arthur Yan
>> Live LeaderboardNew! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (9566)
- More
- Other Specialty
Update on fibroblast growth factor 23 in chronic kidney disease
Kidney International, 05/24/2012
Wolf M – Fibroblast growth factor 23 (FGF23) itself has now been shown to mediate ‘off–target,’ direct, end–organ toxicity in the heart, which suggests that elevated FGF23 levels may be a novel mechanism of adverse outcomes in chronic kidney disease (CKD). This report reviews recent advances in FGF23 biology relevant to CKD, the classical effects of FGF23 on mineral homeostasis, and the studies that established FGF23 excess as a biomarker and novel mechanism of cardiovascular disease.
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Internal Medicine Jobs
@MDLinx Career Center
View the full listing of physician jobs
Sponsor